Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
Apply
Ivosidenib & Enasidenib, Azacitidine, Venetoclax
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step